Why Invest?
Income
We seek to provide predictable, tax-advantaged income for the long-term
Generate current income and, to a lesser extent, capital appreciation
Long-term contractual cash flows with escalators
Capital Preservation
We pursue a diversified portfolio of mission-critical real estate assets, triple net leased to creditworthy, mission critical tenants*.
Net leased medical real estate has fixed income characteristics typically more than “traditional real estate”
VCP focuses on contractual cash flows, credit underwriting, and assets with (relative) lower volatility compared to appreciation-driven real estate.
* Investment grade companies must have "BBB-" rating or higher by S&P or an equivalent rating from a nationally recognized statistical rating organization (NRSRO) at the time of acquisition. Creditworthy refers to businesses that VCP deems financially sound enough to justify an extension of credit or engage in a lease agreement.
Inflation Hedge
Operating expenses are borne by the tenant, offering protection from inflation-driven property expense increases.
NNN leases are leases in which tenants cover taxes, insurance, and maintenance
NNN leased assets produce steadier cash flows and mitigate rising operating expense risk.
Our edge comes from investing in and managing healthcare real estate assets for over a decade and successfully acquiring and exiting over $500m in real estate assets in this sector. Our principals have managed and invested in real estate through various market cycles with success for our institutional and private capital investors.
VCP leverages our decades of experience in underwriting commercial real estate and specifically our decade-long experience in underwriting healthcare tenancy at the operator and reimbursement levels. VCP is focused on sourcing investment opportunities in the institutional medical real estate sector we believe are mispriced due to either market dislocations in current value, or the highly motivated sellers or other capital markets mispricing variables. VCP has deep experience in both clinical outpatient real estate assets and post-acute in-patient healthcare assets.
We believe VCP has a unique competitive advantage with our institutional capital relationship that allows our team to be agile and move quickly on immediate opportunities for surety of close and liquidity. We are extremely focused in healthcare and medical real estate located in primary, secondary, and tertiary markets throughout the Sun Belt and other attractive markets where we believe the barriers to entry are formidable. We believe our affiliations with healthcare systems over the last decade have allowed us to develop unique “healthcare DNA” and has enabled our team to understand the unique aspects of this medical real estate vertical more than many operators in this niche sector.
© Vital Capital Partners. All Rights Reserved.
Statistical data is as of January 2026. Figures are subject to change.
This is for informational purposes only and should not be relied upon as tax or legal advice. Vital Capital Partners does not offer legal or tax advice. Because investor situations and objectives vary this information is not intended to indicate that an investment is appropriate for or is recommended to any individual investor. Please consult the appropriate professional regarding your individual circumstance.
This is neither an offer to sell nor a solicitation of an offer to buy securities described herein. An offering is made only by the Confidential Private Placement Memorandum (PPM). All sale and advertising literature must be read in conjunction with the PPM in order to understand fully all of the implications and risks of the offering to which it relates. A copy of the PPM must be made available to you in connection with an offering. Prospective Members should carefully read the PPM and review any additional information they desire prior to making an investment and should be able to bear the complete loss of their investment.
There are material risks associated with investing in private placements and real estate securities including illiquidity, speculation, general market conditions, interest rate risks, financing risks, potentially adverse tax consequences, general economic risks, development risks, and potential loss of the entire investment principal. Prospective investors should perform their own due diligence carefully and review the “Risk Factors” section of any prospectus, private placement memorandum or offering circular before considering any investment.
DST 1031 properties are only available to accredited investors or accredited entities. If you are unsure if you are an accredited investor and/or an accredited entity, please verify with your CPA and Attorney.
An accredited investor is typically defined as having a $1 million net worth excluding primary residence or $200,000 income individually/$300,000 jointly of the last two years; or have an active Series 7, Series 82, or Series 65. Individuals holding a Series 66 do not fall under this definition) and accredited entities only.
An accredited entity is typically a private business development company or an organization with assets exceeding $5 million; or if an entity consists of equity owners who are accredited investors, the entity itself is an accredited investor provided the organization was not formed with a sole purpose of purchasing specific securities.
Potential cash flows/returns/appreciation are not guaranteed and could be lower than anticipated. Diversification does not guarantee a profit or protect against a loss in a declining market. It is a method used to help manage investment risk.
All forward-looking statements address matters that involve risks and uncertainties and investors should be able to bear the loss of their entire investment. All investors should make their own determination of whether or not to make any investment, based on their own independent evaluation and analysis. Past performance is not indicative of future returns or Fund results. Individual investment performance, examples provided and/or case studies are not indicative of overall returns of the Company. In addition, there can be no guarantee of deal flow in the future. Forward looking statements are not statements of historical fact and reflect the Company’s views and assumptions regarding future events and performance.
The securities are offered in reliance on an exemption from the registration requirements of the Securities Act of 1933, as amended, and are not required to comply with specific disclosure requirements that apply to registration under the Securities Act. Neither the SEC nor any state regulator has reviewed the merits of or given its approval to the securities, the terms of the offerings, or the accuracy or completeness of any offering materials. The securities are subject to legal restrictions on transfer and resale and investors should not assume they will be able to resell their securities.
Vital Capital Partners (“VCP”) offers securities through American Alternative Capital, LLC (AAC), a member FINRA / SIPC. VCP and AAC are independent of each other. For more information on AAC, please visit BrokerCheck.